title: [The advantages of the extra-amniotic transcervical instillation of rivanol in therapeutic abortions (author's transl)].
abstract: Our experience with the transcervical extra-amniotic instillation of 70 ml 0.1% Rivanol solution in 154 cases of first trimestre, second trimestre abortions and intra-uterine fetal deaths is reported. This simple and safe method has several advantages which render it suitable for out-patient usage should the rate of therapeutic abortions increase even more. The gentle dilatatory effect on the cervix is remarkable and is noticeable after 24 hours. Dilatation with the Hegar-dilators becomes unnecessary. There were no major complications. The stress on the patient is minimized.
mesh_terms: D000032:Abortion, Therapeutic; D000166:Acridines / Q000627:therapeutic use*; D004975:Ethacridine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D005313:Fetal Death; D006801:Humans; D011247:Pregnancy; D013997:Time Factors
chemical_list: D000166:Acridines; D004975:Ethacridine
vernacular_title: Vorzüge der transzervikalen extraamnialen Rivanol-Instillation bei der Interruptio.